Literature DB >> 11578807

Distribution of HER2(V655) genotypes in breast cancer cases and controls in the United States.

C Keshava1, E C McCanlies, N Keshava, M S Wolff, A Weston.   

Abstract

The minor variant frequency of a HER2 polymorphism (HER2(V655)) has been determined for 471 United States women enrolled in a multiracial case-control study. Allelic frequencies varied significantly by race. Genotypic distributions showed no excess breast cancer risk associated with inheritance of HER2(V655) either as carriers (OR=1.2, 95% CI=0.8-1.9), heterozygotes (OR=1.2, 95% CI=0.8-1.9), or homozygotes (OR=1.4, 95% CI=0.4-4.2). Nor was there a significant association when each racial group was considered separately. The current study suggests the HER2(V655) allele is not a breast cancer risk factor for Caucasians, African-Americans, or Latinas.

Entities:  

Mesh:

Year:  2001        PMID: 11578807     DOI: 10.1016/s0304-3835(01)00671-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study.

Authors:  Shimian Qu; Qiuyin Cai; Yu-Tang Gao; Wei Lu; Hui Cai; Yinghao Su; Shizhen Emily Wang; Xiao-Ou Shu; Wei Zheng
Journal:  Breast Cancer Res Treat       Date:  2007-08-09       Impact factor: 4.872

2.  A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.

Authors:  Stephanie E Nelson; Michael N Gould; John M Hampton; Amy Trentham-Dietz
Journal:  Breast Cancer Res       Date:  2005-03-11       Impact factor: 6.466

3.  ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancer.

Authors:  Sara Santos; Cláudia S Baptista; Rui M V Abreu; Estela Bastos; Irina Amorim; Ivo G Gut; Fátima Gärtner; Raquel Chaves
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

4.  Dataset reporting detection of breast cancer-related HER2I655V polymorphism using allele-specific polymerase chain reaction.

Authors:  Bugi Ratno Budiarto
Journal:  Data Brief       Date:  2016-09-24

5.  Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study.

Authors:  Patrick R Benusiglio; Fabienne Lesueur; Craig Luccarini; Donald M Conroy; Mitul Shah; Douglas F Easton; Nick E Day; Alison M Dunning; Paul D Pharoah; Bruce Aj Ponder
Journal:  Breast Cancer Res       Date:  2005-01-12       Impact factor: 6.466

6.  Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.

Authors:  Bugi Ratno Budiarto
Journal:  Sci Pharm       Date:  2016-02-14

7.  Her2 Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies.

Authors:  B Madhu Krishna; Sanjib Chaudhary; Aditya K Panda; Dipti Ranjan Mishra; Sandip K Mishra
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.